Kristina M. Deligiannidis, MD

Evolving Research on Postpartum Depression Pathophysiology and Treatment

August 14, 2023

Research on neuroactive steroids reveals their role in perinatal depression, leading to development of novel therapeutics. These emerging treatments hold promise for faster onset and lasting effects.

Kristina M. Deligiannidis, Rubiahna Vaughn

Supplement Article

The GABA Pathway and New Clinical Trial Data in MDD and PPD

March 16, 2023

Studies evaluating neuroactive steroid GABA-A receptor positive allosteric modulators demonstrate promising results for the treatment of MDD and PPD.

Kristina M. Deligiannidis, Anita H. Clayton

Original Research

Effect of Zuranolone on Anxiety and Insomnia in Postpartum Depression

January 30, 2023

Zuranolone was associated with improvements in depressive and anxiety symptoms and was beneficial for insomnia and patient-perceived functional health in patients with PPD.

Kristina M. Deligiannidis, Leslie Citrome, Ming-Yi Huang, et al

ASCP Corner

Long-Acting Injectable Antipsychotic Use During Pregnancy

November 24, 2020

Women with psychotic and mood disorders are at greater risk of symptoms during pregnancy, but some clinicians avoid use of LAIs in these patients due to safety concerns. This...

Sarah A. Reinstein, Jessica Cosgrove, Tara Malekshahi, et al

ASCP Corner

Premenstrual Dysphoric Disorder Treatment

February 4, 2020

Read an article summarizing the treatment options for Premenstrual Dysphoric Disorder (PMDD).

Sara V. Carlini, Kristina M. Deligiannidis

ASCP Corner

Postpartum Psychosis Treatment

November 7, 2017

Read an article summarizing the diagnosis of postpartum psychosis as well as treatment and prevention strategies.

Amanda Tinkelman, Emily A. Hill, Kristina M. Deligiannidis

Original Research

Antidepressant Augmentation Using the N-Methyl-d-Aspartate Antagonist Memantine: A Randomized, Double-Blind, Placebo-Controlled Trial

October 15, 2013

Eric G. Smith, Kristina M. Deligiannidis, Christine M. Ulbricht, et al

Article

A Gender Analysis of the Study of Pharmacotherapy of Psychotic Depression (STOP-PD): Gender and Age as Predictors of Response and Treatment-Associated Changes in Body Mass Index and Metabolic Measures

October 15, 2013

Kristina M. Deligiannidis, Anthony J. Rothschild, Bruce A. Barton, et al

ASCP Corner

Therapeutic Drug Monitoring in Pregnant and Postpartum Women: Recommendations for SSRIs, Lamotrigine, and Lithium

May 15, 2010

Kristina M. Deligiannidis

Kristina M. Deligiannidis, MD

Evolving Research on Postpartum Depression Pathophysiology and Treatment

The GABA Pathway and New Clinical Trial Data in MDD and PPD

Effect of Zuranolone on Anxiety and Insomnia in Postpartum Depression

Long-Acting Injectable Antipsychotic Use During Pregnancy

Premenstrual Dysphoric Disorder Treatment

Postpartum Psychosis Treatment

Antidepressant Augmentation Using the N-Methyl-d-Aspartate Antagonist Memantine: A Randomized, Double-Blind, Placebo-Controlled Trial

A Gender Analysis of the Study of Pharmacotherapy of Psychotic Depression (STOP-PD): Gender and Age as Predictors of Response and Treatment-Associated Changes in Body Mass Index and Metabolic Measures

Therapeutic Drug Monitoring in Pregnant and Postpartum Women: Recommendations for SSRIs, Lamotrigine, and Lithium

ELSEWHERE:

FOLLOW US:

Kristina M. Deligiannidis, MD

Evolving Research on Postpartum Depression Pathophysiology and Treatment

The GABA Pathway and New Clinical Trial Data in MDD and PPD

Effect of Zuranolone on Anxiety and Insomnia in Postpartum Depression

Long-Acting Injectable Antipsychotic Use During Pregnancy

Premenstrual Dysphoric Disorder Treatment

Postpartum Psychosis Treatment

Antidepressant Augmentation Using the N-Methyl-d-Aspartate Antagonist Memantine: A Randomized, Double-Blind, Placebo-Controlled Trial

A Gender Analysis of the Study of Pharmacotherapy of Psychotic Depression (STOP-PD): Gender and Age as Predictors of Response and Treatment-Associated Changes in Body Mass Index and Metabolic Measures

Therapeutic Drug Monitoring in Pregnant and Postpartum Women: Recommendations for SSRIs, Lamotrigine, and Lithium

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles